Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Marker Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:MRKR | Benzinga

Q: What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore Marker Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MRKR.

Open	$1.20
Close	-
Volume / Avg.	1.88M / 113.58K
Day Range	$1.20 - $1.82
52 Wk Range	0.95 - 5.99
Market Cap	$16.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	1.54%
Days to Cover	3

Recent News

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Avi Kapoor

Cancer Cell Therapy Focused Marker Therapeutics Announces Pipeline Prioritization

Marker Therapeutics Inc (NASDAQ: MRKR) announced it is restructuring its clinical programs and strategic prioritization of its multi-tumor associated antigen (multiTAA)-specific T cell product pipeline.

Vandana Singh

Why Is Blood Cancer Focused Marker Therapeutics Stock Trading Higher Today?

Marker Therapeutics Inc (NASDAQ: MRKR) released the preliminary results of the first participant treated with MT-601, its multi-tumor associated antigen (multiTAA)-specific T cell product targeting 6 TAAs, in the Phase 1 multicenter

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$1.20
Close	-
Volume / Avg.	1.88M / 113.58K
Day Range	$1.20 - $1.82
52 Wk Range	0.95 - 5.99
Market Cap	$16.65M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	71
Short Interest	1.54%
Days to Cover	3

About Marker Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Marker Therapeutics (MRKR) stock?

You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.

View our list of the best stock brokerages

Who are Marker Therapeutics (MRKR) competitors?

Other companies in Marker Therapeutics’s space includes: Immuron (NASDAQ:IMRN), Cellectar Biosciences (NASDAQ:CLRB), Can Fite Biofarma (AMEX:CANF), Bolt Biotherapeutics (NASDAQ:BOLT) and BioRestorative Therapies (NASDAQ:BRTX).

What is the forecast, or price target, for Marker Therapeutics (MRKR) stock?

Marker Therapeutics has a consensus price target of $13.17.

What is the current price for Marker Therapeutics (MRKR)?

The stock price for Marker Therapeutics (NASDAQ: MRKR) is $1.5552 last updated May 30, 2025 at 3:47 PM EDT.

Does Marker Therapeutics (MRKR) pay a dividend?

There are no upcoming dividends for Marker Therapeutics.

When is Marker Therapeutics (NASDAQ:MRKR) reporting earnings?

Marker Therapeutics’s Q2 earnings are confirmed for Wednesday, August 13, 2025.

Is Marker Therapeutics (MRKR) going to split?

There is no upcoming split for Marker Therapeutics.

What sector and industry does Marker Therapeutics (MRKR) operate in?

Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Marker Therapeutics Stock Price, Quotes and Forecasts

Marker Therapeutics (MRKR) Forecast